Drawing for PROTEUS

USPTO serial 77981774

PROTEUS

Reviewed by CopyMark Law Group

Reg. 3963272Status 710
Filing date
Status date
Registration date
May 17, 2011
Examiner
ROSSMAN, WILLIAM M
Law office
—

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PROTEUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005[ Ingestible medicated and pharmaceuticals, namely, diagnostic and therapeutic preparations for medical purposes both prescription and over-the-counter, for use in connection with humans and animals, to gather data on patient status and condition, to monitor patient condition, patient adherence to treatment regimens, efficacy of treatment, and to enable personalized therapy for the purpose of maximizing patient outcome in the diagnosis, therapeutic treatment, and management of cancers, chronic pain, skin disease, diseases of the ear, nose, and throat, infectious disease, psychiatric disorders, and diseases of the cardiovascular, respiratory, metabolic, immune, central nervous, endocrine, glandular, musculoskeletal, digestive, excretory, and reproductive systems ]SECTION 8 - CANCELLEDJan 18, 2008
009Data central processing units for processing pharmaceutical or device compliance data, pharmaceutical administration data, device activation data or physiological response data; database computer software for use with medical devices for monitoring administration of pharmaceutical compositions, device activation or physiological responsesSECTION 18 - CANCELLEDJan 18, 2008
010Conductance control devices for use with medical devices for use in administration of pharmaceutical compositions, namely, syringes, catheters, IV bags, infusion pumps for use with IV bags, implantable and topical fluid delivery ports, dialysis machines, inhalers, nebulizers for respiration therapy; medical monitoring devices for use in the administration of pharmaceutical compositions and for use with medical devices in the nature of syringes, catheters, IV bags, infusion pumps for use with IV bags, implantable and topical fluid delivery ports, dialysis machines, inhalers, nebulizers for respiration therapy; implantable electrical stimulation devices, namely, pacemakers, implantable cardioverter-defibrillators; transcutaneous and implantable electrotherapy devices, namely, neurological electrostimulation devices, musculoskeletal electrostimulation devices, respiratory electrostimulation devices, gastro-intestinal electrostimulation devices and electrical stimulation devices for use in stimulating the cardiovascular, respiratory, metabolic, immune, central nervous, endocrine, glandular, musculoskeletal, digestive, excretory, and reproductive systems; implantable physiological medical monitoring devices, namely, heart, gastro-intestinal, respiratory and neurological monitoring devicesSECTION 18 - CANCELLEDJan 18, 2008
041[ Training and teaching in the field of prevention, diagnosis and treatment of medical conditions ]SECTION 8 - CANCELLEDApr 12, 2010
042[ Technical consultancy in the field of the design and development of medical devices and surgical equipment; ] medical research in the field of medical and surgical apparatus, appliances, instruments, therapies and drugs [ ; medical and scientific research in the field of clinical trial services; computer software design for others, computer programming for others, and updating of computer software; maintenance of computer software ]SECTION 18 - CANCELLEDApr 12, 2010
044[ Medical consultation and professional medical consultation in the field of medical and surgical equipment, apparatus, appliances and instruments, medical care, medical therapy and surgery; ] providing health and medical information about medical disorders; information services, namely, providing medical information to chronically ill patients; information services relating to medical services via a global computer network, namely, providing medical consultancy and advisory services via a global computer networkSECTION 18 - CANCELLEDApr 12, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 18, 2022CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Oct 26, 2021TMBNTTAB RELEASE CASE TO TRADEMARKS—
Oct 26, 2021CANTCANCELLATION TERMINATED NO. 999999—
Jul 14, 2021CANGCANCELLATION GRANTED NO. 999999—
Mar 19, 2021PETCCANCELLATION INSTITUTED NO. 999999—
May 17, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 13, 2017NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 13, 2017C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 13, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 17, 2017E815TEAS SECTION 8 & 15 RECEIVED—
Nov 14, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 17, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 17, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 15, 2014NOSUNOTICE OF SUIT—
Jan 15, 2014NOSUNOTICE OF SUIT—
Jan 18, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 18, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 22, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 17, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 14, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 13, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Apr 12, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 11, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 11, 2011DPCCDIVISIONAL PROCESSING COMPLETE—
Mar 30, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 24, 2011IUAFUSE AMENDMENT FILED—
Mar 24, 2011DRRRDIVISIONAL REQUEST RECEIVED—
Mar 24, 2011ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Mar 24, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 10, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 28, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 3, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 3, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 29, 2010ALIEASSIGNED TO LIE—
Jun 16, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jun 16, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 16, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 16, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
May 15, 2010GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
May 15, 2010GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
May 15, 2010CNCFACTION CONTINUING A FINAL - COMPLETED—
Apr 24, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 23, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 23, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 23, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 23, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 23, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 23, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 20, 2009ALIEASSIGNED TO LIE—
Jun 19, 2009RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 19, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 19, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 19, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 19, 2008ALIEASSIGNED TO LIE—
Dec 19, 2007GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 19, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Dec 19, 2007CNSLSUSPENSION LETTER WRITTEN—
Dec 18, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 18, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 19, 2007CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2007DOCKASSIGNED TO EXAMINER—
Mar 7, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance